ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Delivery Microarray Patches Market Research Report 2026
Published Date: 2026-01-07
|
Report Code: QYRE-Auto-22U20084
Home | Market Reports | Health| Medical Devices & Equipment
Global Drug Delivery Microarray Patches Market Research Report 2026
BUY CHAPTERS

Global Drug Delivery Microarray Patches Market Research Report 2026

Code: QYRE-Auto-22U20084
Report
2026-01-07
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
KINDEVA
Raphas
Cosmed Pharmaceutical
Vaxess Technologies
Micron Biomedical
LTS Lohmann Therapie-Systeme
ArrayPatch
CeraVx
Zhongke Microneedle (Beijing) Technology
Zhuhai Youwe Biotechnology
Youwei (Zhuhai) Biotechnology
WCC Biomedical
Hisamitsu Pharmaceutical

Drug Delivery Microarray Patches Market Size

The global Drug Delivery Microarray Patches market was valued at US$ 405 million in 2025 and is anticipated to reach US$ 640 million by 2032, at a CAGR of 6.8% from 2026 to 2032.

Drug Delivery Microarray Patches Market

Drug Delivery Microarray Patches Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug Delivery Microarray Patches competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Drug delivery microarray patches are skin-applied patches that carry a dense array of microscopic projections (microneedles) designed to painlessly breach the outer skin barrier and deposit a drug into the shallow skin layers for absorption. Depending on the design, the microprojections may be dissolving/biodegradable (releasing the dose as the tips dissolve), coated (drug layer transfers off the projections), solid (create microchannels for a separately applied formulation), or hollow (infuse a liquid). Because they can enable simple patch-like self-administration, avoid sharps waste, and potentially improve stability for certain formulations, microarray patches are being developed for vaccines, biologics, and small-molecule therapies where easier delivery and better adherence are valuable. Consumer/cosmetic microneedle patches typically cost between $0.75 and $1.60 per patch. Vaccine microarray patches (MAPs) cost between $0.85 and $5.00 per dose/patch.
Drug delivery microarray patches (MAPs) sit at the intersection of pharma formulation and precision microfabrication. Upstream inputs include the active drug substance (small molecules, biologics, or vaccine antigens), stabilizing excipients (sugars, polymers, buffers, surfactants), and microneedle structural materials (dissolving polymers/sugars for soluble MAPs, or silicon/metal/ceramic/rigid polymers for insoluble designs), plus high-precision tooling and equipment (micro-molds, etching/laser machining, coating/casting and drying systems) and medical-grade converting materials (backing films, pressure-sensitive adhesives, liners, desiccants, foil pouches). Manufacturing then combines microneedle array formation, drug loading (tip-casting, matrix mixing, or surface coating), moisture-controlled drying/curing, lamination/assembly, and rigorous QC for dose uniformity, mechanical strength and insertion performance, extractables/leachables, and stability; depending on product, it may also include sterilization or aseptic controls and an applicator. Downstream, MAPs are supplied as combination products through clinical-trial and commercial channels, with packaging and logistics designed around humidity/temperature sensitivity and traceability; end users range from self-administration at home (chronic therapies) to clinics and mass-immunization programs, with training, labeling, and pharmacovigilance requirements that resemble both drug and device workflows.
The North American market for Drug Delivery Microarray Patches is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Drug Delivery Microarray Patches is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Drug Delivery Microarray Patches include Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Drug Delivery Microarray Patches market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Delivery Microarray Patches. The Drug Delivery Microarray Patches market size, estimates, and forecasts are provided in terms of sales volume (K Pcs) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug Delivery Microarray Patches market comprehensively. Regional market sizes by Type, by Application, by Microneedle Material, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Delivery Microarray Patches manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Drug Delivery Microarray Patches Market Report

Report Metric Details
Report Name Drug Delivery Microarray Patches Market
Accounted market size in 2025 US$ 405 million
Forecasted market size in 2032 US$ 640 million
CAGR 6.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Dissolving
  • Non-dissolving
Segment by Microneedle Material
  • Hyaluronic Acid
  • Taurine
  • Triple-helical Collagen
  • PGA、PLA、PP
by Application
  • Medical
  • Cosmetics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Microneedle Material, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Drug Delivery Microarray Patches manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Drug Delivery Microarray Patches sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Drug Delivery Microarray Patches Market growing?

Ans: The Drug Delivery Microarray Patches Market witnessing a CAGR of 6.8% during the forecast period 2026-2032.

What is the Drug Delivery Microarray Patches Market size in 2032?

Ans: The Drug Delivery Microarray Patches Market size in 2032 will be US$ 640 million.

Who are the main players in the Drug Delivery Microarray Patches Market report?

Ans: The main players in the Drug Delivery Microarray Patches Market are Kindeva, Raphas, CosMED Pharmaceutical, Vaxess Technologies, Micron Biomedical, LTS Lohmann Therapie-Systeme, ArrayPatch, CeraVx, Zhongke Microneedle (Beijing) Technology, Zhuhai Youwe Biotechnology, Youwei (Zhuhai) Biotechnology, WCC Biomedical, Hisamitsu Pharmaceutical

What are the Application segmentation covered in the Drug Delivery Microarray Patches Market report?

Ans: The Applications covered in the Drug Delivery Microarray Patches Market report are Medical, Cosmetics

What are the Type segmentation covered in the Drug Delivery Microarray Patches Market report?

Ans: The Types covered in the Drug Delivery Microarray Patches Market report are Dissolving, Non-dissolving

1 Drug Delivery Microarray Patches Market Overview
1.1 Product Definition
1.2 Drug Delivery Microarray Patches by Type
1.2.1 Global Drug Delivery Microarray Patches Market Value by Type: 2025 vs 2032
1.2.2 Dissolving
1.2.3 Non-dissolving
1.3 Drug Delivery Microarray Patches by Microneedle Material
1.3.1 Global Drug Delivery Microarray Patches Market Value by Microneedle Material: 2025 vs 2032
1.3.2 Hyaluronic Acid
1.3.3 Taurine
1.3.4 Triple-helical Collagen
1.3.5 PGA、PLA、PP
1.4 Drug Delivery Microarray Patches by Application
1.4.1 Global Drug Delivery Microarray Patches Market Value by Application: 2025 vs 2032
1.4.2 Medical
1.4.3 Cosmetics
1.5 Global Drug Delivery Microarray Patches Market Size Estimates and Forecasts
1.5.1 Global Drug Delivery Microarray Patches Revenue 2021–2032
1.5.2 Global Drug Delivery Microarray Patches Sales 2021–2032
1.5.3 Global Drug Delivery Microarray Patches Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Drug Delivery Microarray Patches Market Competition by Manufacturers
2.1 Global Drug Delivery Microarray Patches Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drug Delivery Microarray Patches Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drug Delivery Microarray Patches Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drug Delivery Microarray Patches, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drug Delivery Microarray Patches, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drug Delivery Microarray Patches, Product Types and Applications
2.7 Global Key Manufacturers of Drug Delivery Microarray Patches, Date of Entry into the Industry
2.8 Global Drug Delivery Microarray Patches Market Competitive Situation and Trends
2.8.1 Global Drug Delivery Microarray Patches Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drug Delivery Microarray Patches Players Market Share by Revenue
2.8.3 Global Drug Delivery Microarray Patches Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Delivery Microarray Patches Market Scenario by Region
3.1 Global Drug Delivery Microarray Patches Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drug Delivery Microarray Patches Sales by Region: 2021–2032
3.2.1 Global Drug Delivery Microarray Patches Sales by Region: 2021–2026
3.2.2 Global Drug Delivery Microarray Patches Sales by Region: 2027–2032
3.3 Global Drug Delivery Microarray Patches Revenue by Region: 2021–2032
3.3.1 Global Drug Delivery Microarray Patches Revenue by Region: 2021–2026
3.3.2 Global Drug Delivery Microarray Patches Revenue by Region: 2027–2032
3.4 North America Drug Delivery Microarray Patches Market Facts & Figures by Country
3.4.1 North America Drug Delivery Microarray Patches Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drug Delivery Microarray Patches Sales by Country (2021–2032)
3.4.3 North America Drug Delivery Microarray Patches Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Delivery Microarray Patches Market Facts & Figures by Country
3.5.1 Europe Drug Delivery Microarray Patches Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drug Delivery Microarray Patches Sales by Country (2021–2032)
3.5.3 Europe Drug Delivery Microarray Patches Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Delivery Microarray Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Delivery Microarray Patches Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drug Delivery Microarray Patches Sales by Region (2021–2032)
3.6.3 Asia Pacific Drug Delivery Microarray Patches Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Drug Delivery Microarray Patches Market Facts & Figures by Country
3.7.1 Latin America Drug Delivery Microarray Patches Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drug Delivery Microarray Patches Sales by Country (2021–2032)
3.7.3 Latin America Drug Delivery Microarray Patches Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Drug Delivery Microarray Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Delivery Microarray Patches Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drug Delivery Microarray Patches Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drug Delivery Microarray Patches Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Delivery Microarray Patches Sales by Type (2021–2032)
4.1.1 Global Drug Delivery Microarray Patches Sales by Type (2021–2026)
4.1.2 Global Drug Delivery Microarray Patches Sales by Type (2027–2032)
4.1.3 Global Drug Delivery Microarray Patches Sales Market Share by Type (2021–2032)
4.2 Global Drug Delivery Microarray Patches Revenue by Type (2021–2032)
4.2.1 Global Drug Delivery Microarray Patches Revenue by Type (2021–2026)
4.2.2 Global Drug Delivery Microarray Patches Revenue by Type (2027–2032)
4.2.3 Global Drug Delivery Microarray Patches Revenue Market Share by Type (2021–2032)
4.3 Global Drug Delivery Microarray Patches Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drug Delivery Microarray Patches Sales by Application (2021–2032)
5.1.1 Global Drug Delivery Microarray Patches Sales by Application (2021–2026)
5.1.2 Global Drug Delivery Microarray Patches Sales by Application (2027–2032)
5.1.3 Global Drug Delivery Microarray Patches Sales Market Share by Application (2021–2032)
5.2 Global Drug Delivery Microarray Patches Revenue by Application (2021–2032)
5.2.1 Global Drug Delivery Microarray Patches Revenue by Application (2021–2026)
5.2.2 Global Drug Delivery Microarray Patches Revenue by Application (2027–2032)
5.2.3 Global Drug Delivery Microarray Patches Revenue Market Share by Application (2021–2032)
5.3 Global Drug Delivery Microarray Patches Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Kindeva
6.1.1 Kindeva Company Information
6.1.2 Kindeva Description and Business Overview
6.1.3 Kindeva Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Kindeva Drug Delivery Microarray Patches Product Portfolio
6.1.5 Kindeva Recent Developments/Updates
6.2 Raphas
6.2.1 Raphas Company Information
6.2.2 Raphas Description and Business Overview
6.2.3 Raphas Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Raphas Drug Delivery Microarray Patches Product Portfolio
6.2.5 Raphas Recent Developments/Updates
6.3 CosMED Pharmaceutical
6.3.1 CosMED Pharmaceutical Company Information
6.3.2 CosMED Pharmaceutical Description and Business Overview
6.3.3 CosMED Pharmaceutical Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 CosMED Pharmaceutical Drug Delivery Microarray Patches Product Portfolio
6.3.5 CosMED Pharmaceutical Recent Developments/Updates
6.4 Vaxess Technologies
6.4.1 Vaxess Technologies Company Information
6.4.2 Vaxess Technologies Description and Business Overview
6.4.3 Vaxess Technologies Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Vaxess Technologies Drug Delivery Microarray Patches Product Portfolio
6.4.5 Vaxess Technologies Recent Developments/Updates
6.5 Micron Biomedical
6.5.1 Micron Biomedical Company Information
6.5.2 Micron Biomedical Description and Business Overview
6.5.3 Micron Biomedical Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Micron Biomedical Drug Delivery Microarray Patches Product Portfolio
6.5.5 Micron Biomedical Recent Developments/Updates
6.6 LTS Lohmann Therapie-Systeme
6.6.1 LTS Lohmann Therapie-Systeme Company Information
6.6.2 LTS Lohmann Therapie-Systeme Description and Business Overview
6.6.3 LTS Lohmann Therapie-Systeme Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 LTS Lohmann Therapie-Systeme Drug Delivery Microarray Patches Product Portfolio
6.6.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates
6.7 ArrayPatch
6.7.1 ArrayPatch Company Information
6.7.2 ArrayPatch Description and Business Overview
6.7.3 ArrayPatch Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 ArrayPatch Drug Delivery Microarray Patches Product Portfolio
6.7.5 ArrayPatch Recent Developments/Updates
6.8 CeraVx
6.8.1 CeraVx Company Information
6.8.2 CeraVx Description and Business Overview
6.8.3 CeraVx Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CeraVx Drug Delivery Microarray Patches Product Portfolio
6.8.5 CeraVx Recent Developments/Updates
6.9 Zhongke Microneedle (Beijing) Technology
6.9.1 Zhongke Microneedle (Beijing) Technology Company Information
6.9.2 Zhongke Microneedle (Beijing) Technology Description and Business Overview
6.9.3 Zhongke Microneedle (Beijing) Technology Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Zhongke Microneedle (Beijing) Technology Drug Delivery Microarray Patches Product Portfolio
6.9.5 Zhongke Microneedle (Beijing) Technology Recent Developments/Updates
6.10 Zhuhai Youwe Biotechnology
6.10.1 Zhuhai Youwe Biotechnology Company Information
6.10.2 Zhuhai Youwe Biotechnology Description and Business Overview
6.10.3 Zhuhai Youwe Biotechnology Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zhuhai Youwe Biotechnology Drug Delivery Microarray Patches Product Portfolio
6.10.5 Zhuhai Youwe Biotechnology Recent Developments/Updates
6.11 Youwei (Zhuhai) Biotechnology
6.11.1 Youwei (Zhuhai) Biotechnology Company Information
6.11.2 Youwei (Zhuhai) Biotechnology Description and Business Overview
6.11.3 Youwei (Zhuhai) Biotechnology Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Youwei (Zhuhai) Biotechnology Drug Delivery Microarray Patches Product Portfolio
6.11.5 Youwei (Zhuhai) Biotechnology Recent Developments/Updates
6.12 WCC Biomedical
6.12.1 WCC Biomedical Company Information
6.12.2 WCC Biomedical Description and Business Overview
6.12.3 WCC Biomedical Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 WCC Biomedical Drug Delivery Microarray Patches Product Portfolio
6.12.5 WCC Biomedical Recent Developments/Updates
6.13 Hisamitsu Pharmaceutical
6.13.1 Hisamitsu Pharmaceutical Company Information
6.13.2 Hisamitsu Pharmaceutical Description and Business Overview
6.13.3 Hisamitsu Pharmaceutical Drug Delivery Microarray Patches Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Hisamitsu Pharmaceutical Drug Delivery Microarray Patches Product Portfolio
6.13.5 Hisamitsu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Delivery Microarray Patches Industry Chain Analysis
7.2 Drug Delivery Microarray Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Delivery Microarray Patches Production Mode & Process Analysis
7.4 Drug Delivery Microarray Patches Sales and Marketing
7.4.1 Drug Delivery Microarray Patches Sales Channels
7.4.2 Drug Delivery Microarray Patches Distributors
7.5 Drug Delivery Microarray Patches Customer Analysis
8 Drug Delivery Microarray Patches Market Dynamics
8.1 Drug Delivery Microarray Patches Industry Trends
8.2 Drug Delivery Microarray Patches Market Drivers
8.3 Drug Delivery Microarray Patches Market Challenges
8.4 Drug Delivery Microarray Patches Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
KINDEVA
Raphas
Cosmed Pharmaceutical
Vaxess Technologies
Micron Biomedical
LTS Lohmann Therapie-Systeme
ArrayPatch
CeraVx
Zhongke Microneedle (Beijing) Technology
Zhuhai Youwe Biotechnology
Youwei (Zhuhai) Biotechnology
WCC Biomedical
Hisamitsu Pharmaceutical
List of Tables
 Table 1. Global Drug Delivery Microarray Patches Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Drug Delivery Microarray Patches Market Value by Microneedle Material (US$ Million), 2025 vs 2032
 Table 3. Global Drug Delivery Microarray Patches Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Drug Delivery Microarray Patches Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Drug Delivery Microarray Patches Sales (K Pcs) of Key Manufacturers (2021–2026)
 Table 6. Global Drug Delivery Microarray Patches Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Drug Delivery Microarray Patches Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Drug Delivery Microarray Patches Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Drug Delivery Microarray Patches Average Price (US$/Pc) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Drug Delivery Microarray Patches, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Drug Delivery Microarray Patches, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Drug Delivery Microarray Patches, Product Types and Applications
 Table 13. Global Key Manufacturers of Drug Delivery Microarray Patches, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Drug Delivery Microarray Patches Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Delivery Microarray Patches Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Drug Delivery Microarray Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Drug Delivery Microarray Patches Sales by Region (K Pcs), 2021–2026
 Table 19. Global Drug Delivery Microarray Patches Sales Market Share by Region (2021–2026)
 Table 20. Global Drug Delivery Microarray Patches Sales by Region (K Pcs), 2027–2032
 Table 21. Global Drug Delivery Microarray Patches Sales Market Share by Region (2027–2032)
 Table 22. Global Drug Delivery Microarray Patches Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Drug Delivery Microarray Patches Revenue Market Share by Region (2021–2026)
 Table 24. Global Drug Delivery Microarray Patches Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Drug Delivery Microarray Patches Revenue Market Share by Region (2027–2032)
 Table 26. North America Drug Delivery Microarray Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Drug Delivery Microarray Patches Sales by Country (K Pcs), 2021–2026
 Table 28. North America Drug Delivery Microarray Patches Sales by Country (K Pcs), 2027–2032
 Table 29. North America Drug Delivery Microarray Patches Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Drug Delivery Microarray Patches Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Drug Delivery Microarray Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Drug Delivery Microarray Patches Sales by Country (K Pcs), 2021–2026
 Table 33. Europe Drug Delivery Microarray Patches Sales by Country (K Pcs), 2027–2032
 Table 34. Europe Drug Delivery Microarray Patches Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Drug Delivery Microarray Patches Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Drug Delivery Microarray Patches Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Drug Delivery Microarray Patches Sales by Region (K Pcs), 2021–2026
 Table 38. Asia Pacific Drug Delivery Microarray Patches Sales by Region (K Pcs), 2027–2032
 Table 39. Asia Pacific Drug Delivery Microarray Patches Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Drug Delivery Microarray Patches Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Drug Delivery Microarray Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Drug Delivery Microarray Patches Sales by Country (K Pcs), 2021–2026
 Table 43. Latin America Drug Delivery Microarray Patches Sales by Country (K Pcs), 2027–2032
 Table 44. Latin America Drug Delivery Microarray Patches Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Drug Delivery Microarray Patches Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Drug Delivery Microarray Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Drug Delivery Microarray Patches Sales by Country (K Pcs), 2021–2026
 Table 48. Middle East and Africa Drug Delivery Microarray Patches Sales by Country (K Pcs), 2027–2032
 Table 49. Middle East and Africa Drug Delivery Microarray Patches Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Drug Delivery Microarray Patches Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Drug Delivery Microarray Patches Sales (K Pcs) by Type (2021–2026)
 Table 52. Global Drug Delivery Microarray Patches Sales (K Pcs) by Type (2027–2032)
 Table 53. Global Drug Delivery Microarray Patches Sales Market Share by Type (2021–2026)
 Table 54. Global Drug Delivery Microarray Patches Sales Market Share by Type (2027–2032)
 Table 55. Global Drug Delivery Microarray Patches Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Drug Delivery Microarray Patches Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Drug Delivery Microarray Patches Revenue Market Share by Type (2021–2026)
 Table 58. Global Drug Delivery Microarray Patches Revenue Market Share by Type (2027–2032)
 Table 59. Global Drug Delivery Microarray Patches Price (US$/Pc) by Type (2021–2026)
 Table 60. Global Drug Delivery Microarray Patches Price (US$/Pc) by Type (2027–2032)
 Table 61. Global Drug Delivery Microarray Patches Sales (K Pcs) by Application (2021–2026)
 Table 62. Global Drug Delivery Microarray Patches Sales (K Pcs) by Application (2027–2032)
 Table 63. Global Drug Delivery Microarray Patches Sales Market Share by Application (2021–2026)
 Table 64. Global Drug Delivery Microarray Patches Sales Market Share by Application (2027–2032)
 Table 65. Global Drug Delivery Microarray Patches Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Drug Delivery Microarray Patches Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Drug Delivery Microarray Patches Revenue Market Share by Application (2021–2026)
 Table 68. Global Drug Delivery Microarray Patches Revenue Market Share by Application (2027–2032)
 Table 69. Global Drug Delivery Microarray Patches Price (US$/Pc) by Application (2021–2026)
 Table 70. Global Drug Delivery Microarray Patches Price (US$/Pc) by Application (2027–2032)
 Table 71. Kindeva Company Information
 Table 72. Kindeva Description and Business Overview
 Table 73. Kindeva Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 74. Kindeva Drug Delivery Microarray Patches Product
 Table 75. Kindeva Recent Developments/Updates
 Table 76. Raphas Company Information
 Table 77. Raphas Description and Business Overview
 Table 78. Raphas Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 79. Raphas Drug Delivery Microarray Patches Product
 Table 80. Raphas Recent Developments/Updates
 Table 81. CosMED Pharmaceutical Company Information
 Table 82. CosMED Pharmaceutical Description and Business Overview
 Table 83. CosMED Pharmaceutical Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 84. CosMED Pharmaceutical Drug Delivery Microarray Patches Product
 Table 85. CosMED Pharmaceutical Recent Developments/Updates
 Table 86. Vaxess Technologies Company Information
 Table 87. Vaxess Technologies Description and Business Overview
 Table 88. Vaxess Technologies Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 89. Vaxess Technologies Drug Delivery Microarray Patches Product
 Table 90. Vaxess Technologies Recent Developments/Updates
 Table 91. Micron Biomedical Company Information
 Table 92. Micron Biomedical Description and Business Overview
 Table 93. Micron Biomedical Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 94. Micron Biomedical Drug Delivery Microarray Patches Product
 Table 95. Micron Biomedical Recent Developments/Updates
 Table 96. LTS Lohmann Therapie-Systeme Company Information
 Table 97. LTS Lohmann Therapie-Systeme Description and Business Overview
 Table 98. LTS Lohmann Therapie-Systeme Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 99. LTS Lohmann Therapie-Systeme Drug Delivery Microarray Patches Product
 Table 100. LTS Lohmann Therapie-Systeme Recent Developments/Updates
 Table 101. ArrayPatch Company Information
 Table 102. ArrayPatch Description and Business Overview
 Table 103. ArrayPatch Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 104. ArrayPatch Drug Delivery Microarray Patches Product
 Table 105. ArrayPatch Recent Developments/Updates
 Table 106. CeraVx Company Information
 Table 107. CeraVx Description and Business Overview
 Table 108. CeraVx Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 109. CeraVx Drug Delivery Microarray Patches Product
 Table 110. CeraVx Recent Developments/Updates
 Table 111. Zhongke Microneedle (Beijing) Technology Company Information
 Table 112. Zhongke Microneedle (Beijing) Technology Description and Business Overview
 Table 113. Zhongke Microneedle (Beijing) Technology Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 114. Zhongke Microneedle (Beijing) Technology Drug Delivery Microarray Patches Product
 Table 115. Zhongke Microneedle (Beijing) Technology Recent Developments/Updates
 Table 116. Zhuhai Youwe Biotechnology Company Information
 Table 117. Zhuhai Youwe Biotechnology Description and Business Overview
 Table 118. Zhuhai Youwe Biotechnology Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 119. Zhuhai Youwe Biotechnology Drug Delivery Microarray Patches Product
 Table 120. Zhuhai Youwe Biotechnology Recent Developments/Updates
 Table 121. Youwei (Zhuhai) Biotechnology Company Information
 Table 122. Youwei (Zhuhai) Biotechnology Description and Business Overview
 Table 123. Youwei (Zhuhai) Biotechnology Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 124. Youwei (Zhuhai) Biotechnology Drug Delivery Microarray Patches Product
 Table 125. Youwei (Zhuhai) Biotechnology Recent Developments/Updates
 Table 126. WCC Biomedical Company Information
 Table 127. WCC Biomedical Description and Business Overview
 Table 128. WCC Biomedical Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 129. WCC Biomedical Drug Delivery Microarray Patches Product
 Table 130. WCC Biomedical Recent Developments/Updates
 Table 131. Hisamitsu Pharmaceutical Company Information
 Table 132. Hisamitsu Pharmaceutical Description and Business Overview
 Table 133. Hisamitsu Pharmaceutical Drug Delivery Microarray Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
 Table 134. Hisamitsu Pharmaceutical Drug Delivery Microarray Patches Product
 Table 135. Hisamitsu Pharmaceutical Recent Developments/Updates
 Table 136. Key Raw Materials Lists
 Table 137. Raw Materials Key Suppliers Lists
 Table 138. Drug Delivery Microarray Patches Distributors List
 Table 139. Drug Delivery Microarray Patches Customers List
 Table 140. Drug Delivery Microarray Patches Market Trends
 Table 141. Drug Delivery Microarray Patches Market Drivers
 Table 142. Drug Delivery Microarray Patches Market Challenges
 Table 143. Drug Delivery Microarray Patches Market Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources
 Table 147. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Delivery Microarray Patches
 Figure 2. Global Drug Delivery Microarray Patches Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Drug Delivery Microarray Patches Market Share by Type: 2025 & 2032
 Figure 4. Dissolving Product Picture
 Figure 5. Non-dissolving Product Picture
 Figure 6. Global Drug Delivery Microarray Patches Market Value by Microneedle Material (US$ Million), 2021–2032
 Figure 7. Global Drug Delivery Microarray Patches Market Share by Microneedle Material: 2025 vs 2032
 Figure 8. Hyaluronic Acid Product Picture
 Figure 9. Taurine Product Picture
 Figure 10. Triple-helical Collagen Product Picture
 Figure 11. PGA、PLA、PP Product Picture
 Figure 12. Global Drug Delivery Microarray Patches Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Drug Delivery Microarray Patches Market Share by Application: 2025 & 2032
 Figure 14. Medical
 Figure 15. Cosmetics
 Figure 16. Global Drug Delivery Microarray Patches Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Drug Delivery Microarray Patches Market Size (US$ Million), 2021–2032
 Figure 18. Global Drug Delivery Microarray Patches Sales (K Pcs), 2021–2032
 Figure 19. Global Drug Delivery Microarray Patches Average Price (US$/Pc), 2021–2032
 Figure 20. Drug Delivery Microarray Patches Report Years Considered
 Figure 21. Drug Delivery Microarray Patches Sales Share by Manufacturers in 2025
 Figure 22. Global Drug Delivery Microarray Patches Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Drug Delivery Microarray Patches Players: Market Share by Revenue in Drug Delivery Microarray Patches in 2025
 Figure 24. Drug Delivery Microarray Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Drug Delivery Microarray Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Drug Delivery Microarray Patches Sales Market Share by Country (2021–2032)
 Figure 27. North America Drug Delivery Microarray Patches Revenue Market Share by Country (2021–2032)
 Figure 28. United States Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Drug Delivery Microarray Patches Sales Market Share by Country (2021–2032)
 Figure 31. Europe Drug Delivery Microarray Patches Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Drug Delivery Microarray Patches Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Drug Delivery Microarray Patches Revenue Market Share by Region (2021–2032)
 Figure 39. China Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. China Taiwan Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Southeast Asia Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Drug Delivery Microarray Patches Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Drug Delivery Microarray Patches Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Colombia Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Drug Delivery Microarray Patches Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Drug Delivery Microarray Patches Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. UAE Drug Delivery Microarray Patches Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Drug Delivery Microarray Patches by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Drug Delivery Microarray Patches by Type (2021–2032)
 Figure 59. Global Drug Delivery Microarray Patches Price (US$/Pc) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Drug Delivery Microarray Patches by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Drug Delivery Microarray Patches by Application (2021–2032)
 Figure 62. Global Drug Delivery Microarray Patches Price (US$/Pc) by Application (2021–2032)
 Figure 63. Drug Delivery Microarray Patches Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions